Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-24-192870
Filing Date
2024-08-02
Accepted
2024-08-02 16:11:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d777777dsc13d.htm SC 13D 40907
  Complete submission text file 0001193125-24-192870.txt   42502
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Subject) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93973 | Film No.: 241171097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS, 42ND FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS, 42ND FLOOR NEW YORK NY 10105 917 940 4446
Cortice Biosciences, Inc. (Filed by) CIK: 0002032216 (see all company filings)

EIN.: 262315505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D